Margaret Eidson
University of Miami
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Margaret Eidson.
Public Health Reports | 2002
Christine J Macaluso; Ursula E. Bauer; Larry C. Deeb; John I. Malone; Monika Chaudhari; Janet H. Silverstein; Margaret Eidson; Ronald B. Goldberg; Bonnie Gaughan-Bailey; Robert G. Brooks; Arlan L. Rosenbloom
OBJECTIVES This study was undertaken to examine the trends in the diagnosis of Type 2 diabetes mellitus among children and adolescents with new-onset diabetes seen from 1994 through 1998 at the three university-based diabetes centers in Florida. METHODS Data were abstracted from medical records and patients were categorized as having Type 1 or Type 2 diabetes. RESULTS There were 569 patients classified with Type 1 diabetes and 92 with Type 2 diabetes. The proportion of patients diagnosed with Type 2 diabetes increased over the five years from 9.4% in 1994 to 20.0% in 1998 (chi-square test for trend = 8.2; p=0.004). There was not an associated net increase in the total number of new diabetes patients referred over time (chi-square test for trend = 0.6, p=0.4). Those with Type 2 diabetes were more likely to have a body mass index in the 85th-94th percentile [odds ratio (OR) = 8.5; 95% confidence interval (CI) 2.5, 28.8], have a body mass index >or=95th percentile (OR = 6.8; 95% CI 2.6, 17.7), Hispanic ethnicity (OR = 6.2; 95% CI 2.2, 17.9), black race (OR = 2.8; 95% CI 1.3, 6.2), female gender (OR = 2.2; 95% CI 1.2, 4.3), and older age (OR = 1.4 for each one-year increment in age; 95% CI 1.3, 1.6), compared with those having Type 1 diabetes. CONCLUSIONS From 1994 through 1998, there was a significant overall increase in the percentage of children referred with new-onset diabetes who were considered to have Type 2 diabetes. Factors associated with the diagnosis of Type 2 diabetes relative to Type 1 diabetes include body mass index >/=85th percentile, Hispanic ethnicity, black race, female gender, and older age.
Pediatric Diabetes | 2010
Anna Maria Patiño-Fernández; Alan M. Delamater; E. Brooks Applegate; Erika Brady; Margaret Eidson; Robin Nemery; Luis Gonzalez-Mendoza; Samuel Richton
Patiño‐Fernández AM, Delamater AM, Applegate EB, Brady E, Eidson M, Nemery R, Gonzalez‐Mendoza L, Richton S. Neurocognitive functioning in preschool‐age children with type 1 diabetes mellitus.
The Diabetes Educator | 2008
Farrah Jacquez; Stacey Stout; Rose Alvarez-Salvat; M. Fernández; Manuela Villa; Janine Sanchez; Margaret Eidson; Robin Nemery; Alan M. Delamater
Purpose The purpose of this study is to investigate parent reports of the diabetes care support their children receive in school, their concerns about diabetes management in school, and their knowledge of federal laws that protect children with diabetes. In addition, the study explores ethnic and socioeconomic status differences in diabetes management in school. Methods An ethnically heterogeneous sample of 309 parents of children with diabetes was recruited from a community-based and a university-based diabetes outpatient clinic. Parents completed a survey assessing supports their childs school provides for diabetes care, worries about diabetes care in school, and awareness of federal laws that pertain to children with diabetes. Results Many children did not have a written care plan or a nurse at school, but significantly more white children had these supports than Hispanic or black children. Most children were not allowed to check blood glucose levels or administer insulin in class. Most parents were worried about hyperglycemia and hypoglycemia in school, and most were not at all or only a little confident in the schools ability to care for diabetes. Most parents were not aware of federal laws, but high-income and white parents were more likely to be aware. Conclusions According to parents in the current study, children receive inadequate diabetes management support in schools. Minority children are less likely to receive supports than white children. Parents are worried about diabetes management in school, but most do not have the knowledge of federal laws necessary to protect their children.
Pediatric Research | 1994
Philippe F Backeljauw; Cresio Alves; Margaret Eidson; William W. Cleveland; Louis E. Underwood; Marsha L. Davenport
ABSTRACT: Leprechaunism (Donohue syndrome) is an autosomal recessive disorder characterized by hyperglycemia, extreme insulin resistance, dysmorphic features, failure to thrive, and early death. In this study, recombinant IGF-I, which has both insulin-like and anabolic effects, was administered to two infants with leprechaunism in an attempt to reduce hyperglycemia and improve nutritional status. IGF-I was infused for 66 h in patient FL-1 and 62 h in patient NC-2, with maximal infusion rates of 110 and 40 μg/kg/h, respectively. Although supraphysiologic concentrations of IGF-I were achieved (459 and 1583 μg/L in FL-1 and NC-2, respectively), there were no apparent glucoselowering or nitrogen-sparing effects. Insulin concentrations decreased from extremely high values (16804 and 10224 μmol/L) but remained elevated (611 pmol/L in FL-1 and 5869 pmol/L in NC-2). No changes in serum and urinary urea nitrogen or electrolytes occurred. IGF binding protein-2, which was the predominant IGF binding protein in serum by ligand blot and immunoblot, did not change with IGF-I infusion. IGF binding protein-3 levels were low at baseline and increased slightly during the infusion. We hypothesize that the lack of significant glucose-lowering and anabolic responses to IGF-I could be secondary to a postreceptor defect in IGF-I signaling resulting from the absence of functional insulin receptors.
American Journal of Medical Genetics | 1998
William H. Hoffman; Kalman Kovacs; Shibo Li; Anita S. Kulharya; Bruce L. Johnson; Margaret Eidson; William W. Cleveland
We report on two adolescent boys with Kenny-Caffey syndrome and microorchidism. The first patient had elevated levels of serum follicle-stimulating hormone, but normal levels of luteinizing hormone and testosterone. There was no evidence of a microdeletion of the Y chromosome. The second patient had Leydig cell hyperplasia with normal seminiferous tubules and spermatogenesis, and normal pituitary histologic findings at autopsy. The presence of microorchidism in these patients confirms the previous observations and suggests subfertility, but does not fully clarify the pathogenesis.
Journal of Pediatric Psychology | 2001
Alan M. Delamater; Kimberly Shaw; Annette M. La Greca; Margaret Eidson; Jose E. Perez-Rodriguez; Robin Nemery
Diabetes Care | 1999
Alan M. Delamater; K H Shaw; E B Applegate; I A Pratt; Margaret Eidson; G X Lancelotta; L Gonzalez-Mendoza; S Richton
Journal of Pediatric Psychology | 2006
J. M. Valenzuela; Anna Maria Patino; Judith McCullough; Christine Ring; Janine Sanchez; Margaret Eidson; Robin Nemery; Alan M. Delamater
Journal of Pediatric Psychology | 2005
Anna Maria Patino; Janine Sanchez; Margaret Eidson; Alan M. Delamater
The Journal of Nuclear Medicine | 1999
George N. Sfakianakis; Shabbir Ezuddin; Janine Sanchez; Margaret Eidson; William W. Cleveland